Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof...

C - Chemistry – Metallurgy – 12 – N

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12N 15/18 (2006.01) A61K 38/18 (2006.01) C07K 14/71 (2006.01) A61K 38/00 (2006.01)

Patent

CA 2191071

Disclosed is an altered, soluble form of the FLT polypeptide being capable of binding to VEGF and thereby exerting an inhibitory effect thereon, the polypeptide comprising five or fewer complete immunoglobulin-like domains, together with pharmaceutical compositions comprising the polypeptide, and various uses thereof.

On décrit une forme soluble modifiée du polypeptide du récepteur de la tyrosine kinase (FLT), capable de se lier au facteur de croissance de cellules endothéliales vasculaires (VEGF) et d'exercer ainsi un effet inhibiteur sur celui-ci, ce polypeptide comprenant au maximum cinq domaines complets de type immunoglobuline. On décrit également les compositions pharmaceutiques comprenant ce polypeptide ainsi que diverses utilisations de celui-ci.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Flt-4 (fms-like tyrosine kinase), flt-15, variants thereof... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1442023

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.